The University of Ghana Medical School (UGMS) has denied reports that a cassava-based compound known as “cassavarin” has been developed to reverse Type 2 diabetes.
Contrary to the reports, it said no such study has been conducted, nor has any compound by that name been isolated.
It also stated that it has not undertaken clinical trials of the nature described, adding that claims regarding regulatory approvals, pharmaceutical lawsuits, and licensing are fabricated.
“The University of Ghana Medical School maintains the highest standards of scientific integrity and ethical research practice. Members of the public are advised to rely only on information released through official University of Ghana channels.”
UGMS further noted that it was taking the appropriate steps to address the ongoing misinformation.
Story by Hajara Fuseini
Click to read more: https://opemsuo.com/author/hajara-fuseini/
